Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

Related Articles by Review for PubMed (Select 21070833)

1.

Consequences of POR mutations and polymorphisms.

Miller WL, Agrawal V, Sandee D, Tee MK, Huang N, Choi JH, Morrissey K, Giacomini KM.

Mol Cell Endocrinol. 2011 Apr 10;336(1-2):174-9. doi: 10.1016/j.mce.2010.10.022. Epub 2010 Nov 9.

PMID:
21070833
2.

P450 oxidoreductase deficiency: a disorder of steroidogenesis with multiple clinical manifestations.

Miller WL.

Sci Signal. 2012 Oct 23;5(247):pt11. doi: 10.1126/scisignal.2003318. Review.

PMID:
23092891
3.

Genetic variation in human P450 oxidoreductase.

Miller WL, Huang N, Agrawal V, Giacomini KM.

Mol Cell Endocrinol. 2009 Mar 5;300(1-2):180-4. doi: 10.1016/j.mce.2008.09.017. Epub 2008 Sep 26. Review.

PMID:
18930113
4.

P450 oxidoreductase deficiency: a new disorder of steroidogenesis.

Miller WL, Huang N, Pandey AV, Flück CE, Agrawal V.

Ann N Y Acad Sci. 2005 Dec;1061:100-8. Review.

PMID:
16467261
5.

Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase.

Flück CE, Nicolo C, Pandey AV.

Fundam Clin Pharmacol. 2007 Aug;21(4):399-410. Review.

PMID:
17635179
6.

[Antley-Bixler syndrome or POR deficiency?].

Tomková M, Marohnic CC, Baxová A, Martásek P.

Cas Lek Cesk. 2008;147(5):261-5. Review. Czech.

PMID:
18630181
7.

Pharmacogenomics of human P450 oxidoreductase.

Pandey AV, Sproll P.

Front Pharmacol. 2014 May 9;5:103. doi: 10.3389/fphar.2014.00103. eCollection 2014. Review.

8.

P450 oxidoreductase deficiency - a new form of congenital adrenal hyperplasia.

Flück CE, Pandey AV, Huang N, Agrawal V, Miller WL.

Endocr Dev. 2008;13:67-81. doi: 10.1159/000134826. Review.

PMID:
18493134
9.

Clinical and biochemical consequences of p450 oxidoreductase deficiency.

Flück CE, Pandey AV.

Endocr Dev. 2011;20:63-79. doi: 10.1159/000321221. Epub 2010 Dec 16. Review.

PMID:
21164260
10.

Minireview: regulation of steroidogenesis by electron transfer.

Miller WL.

Endocrinology. 2005 Jun;146(6):2544-50. Epub 2005 Mar 17. Review.

PMID:
15774560
11.

Pharmacogenetics of P450 oxidoreductase: implications in drug metabolism and therapy.

Hu L, Zhuo W, He YJ, Zhou HH, Fan L.

Pharmacogenet Genomics. 2012 Nov;22(11):812-9. doi: 10.1097/FPC.0b013e328358d92b. Review.

PMID:
23047293
12.

NADPH P450 oxidoreductase: structure, function, and pathology of diseases.

Pandey AV, Flück CE.

Pharmacol Ther. 2013 May;138(2):229-54. doi: 10.1016/j.pharmthera.2013.01.010. Epub 2013 Jan 24. Review.

PMID:
23353702
13.

P450 oxidoreductase: genetic polymorphisms and implications for drug metabolism and toxicity.

Hart SN, Zhong XB.

Expert Opin Drug Metab Toxicol. 2008 Apr;4(4):439-52. doi: 10.1517/17425255.4.4.439 . Review.

PMID:
18433346
14.

Genetic and clinical features of p450 oxidoreductase deficiency.

Scott RR, Miller WL.

Horm Res. 2008;69(5):266-75. doi: 10.1159/000114857. Epub 2008 Feb 6. Review.

15.

P450 oxidoreductase deficiency: a new disorder of steroidogenesis with multiple clinical manifestations.

Miller WL.

Trends Endocrinol Metab. 2004 Sep;15(7):311-5. Review.

PMID:
15350602
16.

Genetics of congenital adrenal hyperplasia.

Krone N, Arlt W.

Best Pract Res Clin Endocrinol Metab. 2009 Apr;23(2):181-92. doi: 10.1016/j.beem.2008.10.014. Review.

PMID:
19500762
17.
18.

Disorders of androgen synthesis--from cholesterol to dehydroepiandrosterone.

Miller WL.

Med Princ Pract. 2005;14 Suppl 1:58-68. Review.

PMID:
16103714
19.

P450 oxidoreductase deficiency and Antley-Bixler syndrome.

Arlt W.

Rev Endocr Metab Disord. 2007 Dec;8(4):301-7. Review.

PMID:
17960482
20.

Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.

Zhou SF.

Clin Pharmacokinet. 2009;48(11):689-723. doi: 10.2165/11318030-000000000-00000. Review.

PMID:
19817501
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk